SEARCH

SEARCH BY CITATION

References

  • Ai J., Liu E., Wang J., Chen Y., Yu J. and Baker A. J. (2007) Calpain inhibitor MDL-28170 reduces the functional and structural deterioration of corpus callosum following fluid percussion injury. J. Neurotrauma 24, 960978.
  • Bartus R. (1997) The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway. Neuroscientist 3, 314327.
  • Brophy G. M., Pineda J. A., Papa L. et al. (2009) alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. J. Neurotrauma 26, 471479.
  • Buki A., Siman R., Trojanowski J. Q. and Povlishock J. T. (1999) The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J. Neuropathol. Exp. Neurol. 58, 365375.
  • Deng Y., Thompson B. M., Gao X. and Hall E. D. (2007) Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury. Exp. Neurol. 205, 154165.
  • Farkas O., Polgar B., Szekeres-Bartho J., Doczi T., Povlishock J. T. and Buki A. (2005) Spectrin breakdown products in the cerebrospinal fluid in severe head injury–preliminary observations. Acta Neurochir. (Wien) 147, 855861.
  • Hall E. D., Bryant Y. D., Cho W. and Sullivan P. G. (2008) Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. J. Neurotrauma 25, 235247.
  • Kampfl A., Posmantur R., Nixon R., Grynspan F., Zhao X., Liu S. J., Newcomb J. K., Clifton G. L. and Hayes R. L. (1996) mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J. Neurochem. 67, 15751583.
  • Kampfl A., Posmantur R. M., Zhao X., Schmutzhard E., Clifton G. L. and Hayes R. L. (1997) Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J. Neurotrauma 14, 121134.
  • Koumura A., Nonaka Y., Hyakkoku K., Oka T., Shimazawa M., Hozumi I., Inuzuka T. and Hara H. (2008) A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-met hylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice. Neuroscience 157, 309318.
  • Kupina N. C., Nath R., Bernath E. E., Inoue J., Mitsuyoshi A., Yuen P. W., Wang K. K. and Hall E. D. (2001) The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. J. Neurotrauma 18, 12291240.
  • Kupina N. C., Detloff M. R., Bobrowski W. F., Snyder B. J. and Hall E. D. (2003) Cytoskeletal protein degradation and neurodegeneration evolves differently in males and females following experimental head injury. Exp. Neurol. 180, 5573.
  • Mbye L. H., Singh I. N., Carrico K. M., Saatman K. E. and Hall E. D. (2009) Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury. J. Cereb. Blood Flow Metab. 29, 8797.
  • McCracken E., Hunter A. J., Patel S., Graham D. I. and Dewar D. (1999) Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J. Neurotrauma 16, 749761.
  • McIntosh T., Saatman K. E. and Raghupathi R. (1997) Calcium and the pathogenesis of traumatic CNS injury: cellular and molecular mechanisms. Neuroscientist 3, 169175.
  • Mellgren R., Zhang W., Miyake K. and McNeil P. (2007) Calpain is required for the rapid, calcium-dependent repair of the wounded plasma membrane. J. Biol. Chem. 282, 25672575.
  • Mellgren R., Miyake K., Kramerova I., Spencer M., Bourg N., Bartoli M., Richard I., Greer P. and McNeil P. (2009) Calcium-dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases. Biochim. Biophys. Acta 1793, 18861893.
  • Mustafa A. G., Wang J. A., Carrico K. M. and Hall E. D. (2011) Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury. J. Neurochem. 117, 579588.
  • Oka T., Walkup R. D., Tamada Y., Nakajima E., Tochigi A., Shearer T. R. and Azuma M. (2006) Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-me thylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester. Neuroscience 141, 21392145.
  • Posmantur R., Kampfl A., Siman R., Liu J., Zhao X., Clifton G. L. and Hayes R. L. (1997) A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77, 875888.
  • Saatman K. E., Bozyczko-Coyne D., Marcy V., Siman R. and McIntosh T. K. (1996a) Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 55, 850860.
  • Saatman K. E., Murai H., Bartus R. T., Smith D. H., Hayward N. J., Perri B. R. and McIntosh T. K. (1996b) Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc. Natl Acad. Sci. USA 93, 34283433.
  • Saatman K. E., Creed J. and Raghupathi R. (2010) Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 7, 3142.
  • Shirasaki Y., Yamaguchi M. and Miyashita H. (2006) Retinal penetration of calpain inhibitors in rats after oral administration. J. Ocul. Pharmacol. Ther. 22, 417424.
  • Shirasaki Y., Takahashi H., Yamaguchi M. and Inoue J. (2008) Molecular design to enhance the penetration into the retina via ocular instillation. Bioorg. Med. Chem. Lett. 18, 51745177.
  • Thompson S. N., Gibson T. R., Thompson B. M., Deng Y. and Hall E. D. (2006) Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice. Exp. Neurol. 201, 253265.
  • Thompson S. N., Carrico K. M., Mustafa A. G., Bains M. and Hall E. D. (2010) A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model. J. Neurotrauma 27, 22332243.
  • Wang K. K. W. (2000) Calpain and caspase: can you tell the difference? Trends Neurosci. 23, 2026.
  • Yoshikawa Y., Zhang G. X., Obata K., Ohga Y., Matsuyoshi H., Taniguchi S. and Takaki M. (2010) Cardioprotective effects of a novel calpain inhibitor SNJ-1945 for reperfusion injury after cardioplegic cardiac arrest. Am. J. Physiol. Heart Circ. Physiol. 298, H643H651.